We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
The question of who should tweak works, and when, baffles fans and authors alike
Industry rejects call for transparency over use of strategy that can delay competition from generic medicines
Specialist drugs sold by Big Pharma are so expensive that many patients are being excluded
Role-playing games like Dungeons & Dragons are having a moment in the spotlight – and offer valuable lessons to the rest of the economy
Manufacturers showed during the pandemic that they can deliver low-cost treatments at scale
New York jury rejected artist’s claim that digital depictions of luxury bags was legally protected expression
Apply for the 2023 ranking, and read last year’s coverage
Clients and peers are invited to recommend firms and rate them for specialist expertise
Amgen to launch ‘biosimilar’ version of medicine that has generated $200bn in sales since launch
Millions of pounds are being invested to turn scientific research into global companies. But some founders say they have to give up too much equity
Platform aims to increase transparency on provenance of pieces from smaller makers, boosting resale potential
Getty Images and others are challenging AI companies’ use of copyrighted images to train their image-generating algorithms
Skynet hits the books
Bloc asks global body to convene panels to rule on two trade disputes
Ending of pharma group’s IP truce spells fight for future of mRNA technology
Pharma company still ‘eager’ to collaborate with Beijing, despite collapse of initial talks
Lawsuit centres on US company’s purchase of start-up Nuvia
Foreign companies are finally winning the battle to trademark names — but is the cost worth it?
US biotech claims rival Covid vaccine makers infringed patents underpinning jabs developed to combat the pandemic
Company is being sued over allegations it overcharged millions of customers
A decision by the Japan Patent Office appears to credit the consumer with more discernment than trademark owners do
It’s not just million-dollar paintings. The race is on to track down the everyday objects that are looted in war
Ruling will enable luxury British shoemaker to sell in country directly for first time
Pharma group seeks compensation from Covid vaccine maker for alleged IP infringements
Landmark case signals shift for consumers towards mass lawsuits over antitrust breaches
International Edition
